Airway Therapeutics

Biologics & Biosimilars · Infectious Disease Therapeutics
Data updated Nov 21, 2026Money ledger: 2 records from 1 sourceFiled 2Full reportReport a mistake

Facts

as of Nov 21, 2026

OUR VISION. We envision a future where our immune-modulating therapies fundamentally change how we prevent and treat respiratory, inflammatory, and infectious diseases.

Legal name
Airway Therapeutics, Inc.
Headquarters
Marietta, United States
Employees
12US Form 5500 (plan participants) · Dec 2025 · +71% in a year
Register numbers
EIN 452204067
Official records
SEC CIK 1733867

These are the key facts about Airway Therapeutics on Alion as of Nov 21, 2026. Airway Therapeutics is headquartered in Marietta, United States. It has raised $54.4M in 2 funding rounds. The latest round is Venture - Series Unknown of $43.5M, announced in 2026.

Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

Airway Therapeutics has $54.4M paid in by investors, lenders and donors.

$54.4MPaid in
Money innewest first
Equity raised
Aug 2026 · Venture round
$43.5MPaid
Equity raised
Mar 2018 · Venture round
$10.9MPaid
Money by yearUSD, rounds and grants
2026$43.5M1 record
2018$10.9M1 record
Every row links its own source. A flow two sources state counts once; a figure a source does not state reads "not stated".

People

12EmployeesUS Form 5500 (plan participants) · Dec 2025 · +71% in a year
Head countas filed and stated

Products

Products →

Airway Therapeutics has 3 clinical trials on record, 1 under way.

Clinical trials
Efficacy and Safety of Zelpultide Alfa in Preterm Neonates at High Risk of Developing Bronchopulmonary Dysplasia (BPD)
phase 3 · under way · 366 participants · Bronchopulmonary Dysplasia
Feb 2025
A Clinical Safety Study of AT-100 (rhSP-D) in Preterm Neonates at High Risk for Bronchopulmonary Dysplasia (BPD)
phase 1 · completed · 37 participants · Bronchopulmonary Dysplasia
Sep 2021
A Clinical Safety Study on AT-100 in Treating Adults With Severe COVID-19 Infection or Severed Community Acquired Pneum…
phase 1 · stopped or withdrawn · 5 participants · COVID-19; Undefined
Aug 2021
Source: each app’s App Store and Google Play page (an app counts as the company’s when its developer site is on the company’s domain); the products its own site names.

What the registers and the postings say about this employer.

Legal entity active
Airway Therapeutics, Inc.
Not checked
Sanctions lists
OFAC SDN, EU consolidated · sanctionssearch.ofac.treas.gov ↗
No match
Phishing reports
OpenPhish, Phishing.Database · openphish.com ↗
None
Layoff notices
US WARN notices on file · dol.gov ↗
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Milestones

2025
Team of 12 was 7 · US Form 5500 (plan participants)
Mar 1, 2018
Each milestone is dated by its source: registers, filings, the press